Press coverage about Aethlon Medical (NASDAQ:AEMD) has trended somewhat positive recently, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aethlon Medical earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 46.4399515063139 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Several equities analysts have recently commented on AEMD shares. ValuEngine upgraded shares of Aethlon Medical from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st. HC Wainwright started coverage on shares of Aethlon Medical in a report on Monday, November 20th. They issued a “buy” rating and a $3.00 price objective on the stock.
Shares of Aethlon Medical (AEMD) traded up $0.02 during mid-day trading on Friday, hitting $1.07. 135,418 shares of the stock traded hands, compared to its average volume of 475,981. The company has a current ratio of 2.97, a quick ratio of 2.97 and a debt-to-equity ratio of 78.00. Aethlon Medical has a 52-week low of $0.79 and a 52-week high of $5.17.
WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Aethlon Medical (AEMD) Stock Price” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://sportsperspectives.com/2017/11/25/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-aethlon-medical-aemd-stock-price.html.
About Aethlon Medical
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.